Global Viscosupplementation Injection Market Growth 2023-2029

Global Viscosupplementation Injection Market Growth 2023-2029

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.
Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
LPI (LP Information)' newest research report, the “Viscosupplementation Injection Industry Forecast” looks at past sales and reviews total world Viscosupplementation Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Viscosupplementation Injection sales for 2023 through 2029. With Viscosupplementation Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viscosupplementation Injection industry.
This Insight Report provides a comprehensive analysis of the global Viscosupplementation Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Viscosupplementation Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Viscosupplementation Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viscosupplementation Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viscosupplementation Injection.
The global Viscosupplementation Injection market size is projected to grow from US$ 1115.4 million in 2022 to US$ 1667.5 million in 2029; it is expected to grow at a CAGR of 1667.5 from 2023 to 2029.
The classification of Viscosupplementation Injection includes Single Injection, Three Injection, Five Injection, and the sales share of Single Injection take about 40%.
Viscosupplementation Injection is widely used in hospitals, clinics and other place. The most proportion of Viscosupplementation Injection used in Hospitals, and the proportion is 55%.
North America is the largest consumption place, with a consumption market share nearly 52%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 28%.
Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 63% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Viscosupplementation Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Single Injection
Three Injection
Five Injection
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Key Questions Addressed in this Report
What is the 10-year outlook for the global Viscosupplementation Injection market?
What factors are driving Viscosupplementation Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Viscosupplementation Injection market opportunities vary by end market size?
How does Viscosupplementation Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.